title: Treatment of acquired perforating dermatosis with cantharidin.
authors.affiliation: Faculty of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
authors.forename: Jessica
authors.initials: J
authors.lastname: Wong
authors.forename: Robert
authors.initials: R
authors.lastname: Phelps
authors.forename: Jacob
authors.initials: J
authors.lastname: Levitt
mesh_terms: D000368:Aged; D018926:Anti-Allergic Agents / Q000627:therapeutic use; D002193:Cantharidin / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007641:Keratolytic Agents / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000628:therapy; D009539:Nicotinic Acids / Q000627:therapeutic use; D010530:Peritoneal Dialysis; D012871:Skin Diseases / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D016593:Terfenadine / Q000031:analogs & derivatives / Q000627:therapeutic use; D012176:Retinoids
chemical_list: D018926:Anti-Allergic Agents; D002193:Cantharidin; D003879:Dermatologic Agents; D007641:Keratolytic Agents; D009539:Nicotinic Acids; D016593:Terfenadine; C086827:tazarotene; D012176:Retinoids; C093230:fexofenadine